Table 1 Patient demographics.
From: Small-molecule metabolome identifies potential therapeutic targets against COVID-19
Patient group | ||||
|---|---|---|---|---|
SARS-COV-2 (COV) | Influenza A (INFA) | Respiratory Syncytial Virus (RSV) | Unaffected Controls | |
N | 55 | 55 | 56 | 44 |
Year of collection (range in months) | 2020 (Jan–Apr) | 2019–2020 (Dec–Mar) | 2019–2020 (Dec–Mar) | 2020 (Sept) |
Median age (range) | 55 years (20–85 years) | 62 years (27 days–94 years) | 16 months (21 days–91 years) | 24 years (19–43 years) |
Sex (%) | M 27% F 42% n/a 31% | M 54% F 44% n/a 2% | M 40% F 46% n/a 14% | M 25% F 75% |
Median CTa (range) | 26.2 (17.76–37.24) | 28.6 (21.43–38.6) | 26.3 (18.54–36.87) | N/A |
